Jon Freels, MD
Pulmonologist
Asbestosis Lung Cancer Pleural Effusions Pleural Plaques Pleuritis Testicular Mesothelioma
Dr. Freels graduated the medical school from the University of Arizona College of Medicine and did his residency at the same university, where a fellowship also followed soon after that. He is specialized in Pulmonology and board certified in Pulmonary Disease. Dr. Freels has been in practice for more than 11 years and is affiliated with the Maury Regional Hospital. During his career, he has also contributed to 4 publications of medical interest.
University of Arizona College of Medicine - Tucson
Medical School
University of Arizona
Residency
University of Arizona
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Pulmonary Disease
TN State Medical License: 2004 - 2016
American Board of Internal Medicine: Pulmonary Disease
American Board of Internal Medicine: Internal Medicine
16 citations Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts.
Numanami, H., Koyama, S., Nelson, D.K., Hoyt, J.C., Freels, J.L., Habib, M.P., Amano, J., Haniuda, M., Sato, E., Robbins, R.A.; Am J Respir Cell Mol Biol. 2003 Nov.
See more >>1 citation Peroxynitrite enhances interleukin-10 reduction in the release of neutrophil chemotactic activity.
Numanami, H., Nelson, D.K., Hoyt, J.C., Freels, J.L., Habib, M., Amano, J., Haniuda, M., Koyama, S., Robbins, R.A.; Am J Respir Cell Mol Biol. 2003 Aug.
See more >>11 citations Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro.
Numanami, H., Koyama, S., Sato, E., Haniuda, M., Nelson, D.K., Hoyt, J.C., Freels, J.L., Habib, M.P., Robbins, R.A.; Am J Physiol Lung Cell Mol Physiol. 2003 May.
See more >>